
For senior citizens who take longer to recover from operations, Platelet Rich Plasma (PRP) treatment, a blood plasma injection with the patient's own blood, is being considered a new alternative to knee surgery.
Doctors said PRP injections deliver a high concentration of growth factors to arthritic cartilage which can potentially enhance healing.
Advertisement
‘Plasma rich protein injection activates growth factors and stem cells to help repair the tissue, decrease inflammation and thereby reducing the osteoarthritic symptoms.’
Tweet it Now
"Treatment with PRP is useful in improving pain, stiffness and function. The recent example is a 70-year-old patient who was suggested knee surgery but was reluctant following the late recovery at such age. So we suggested PRP injection. The patient now has completely recovered," said Pradeep Moonot, orthopaedic surgeon at Breach Candy Super Specialty Hospital in Mumbai.
"PRP, unlike the synthetic injections, is a biological injection which is produced from patient's own blood.
"It's a simple process where we take patient's blood, and spin it down, concentrate the platelets, and inject it back into their knee with their own platelets in a concentrated form. This activates growth factors and stem cells to help repair the tissue, decrease inflammation and thereby reducing the osteoarthritic symptoms," said Moonot.
According to doctors, the entire process takes only 2-3 hours and does not require hospital admission.
Every year, over two lakh Indians undergo knee surgery and half of them after the age of 50, which requires a good amount of rehabilitation post surgery.
Elaborating, he said the only thing with PRP injection was that it starts showing results only after 4-6 weeks, so the patient should not come with an intention of immediate results.
Deepak Raheja, an orthopaedic surgeon at AIIMS, said PRP injection was an economically viable option as it costs about one-tenth of a knee replacement surgery.
"Since it is a biological injection, like mentioned earlier, its impact may vary from patient to patient. There are various studies which show that in at least 73 percent of cases, there were clinical and functional benefits and no progression of arthritis up to one year," he said.
Source: IANS
"It's a simple process where we take patient's blood, and spin it down, concentrate the platelets, and inject it back into their knee with their own platelets in a concentrated form. This activates growth factors and stem cells to help repair the tissue, decrease inflammation and thereby reducing the osteoarthritic symptoms," said Moonot.
Advertisement
According to doctors, the entire process takes only 2-3 hours and does not require hospital admission.
Every year, over two lakh Indians undergo knee surgery and half of them after the age of 50, which requires a good amount of rehabilitation post surgery.
Elaborating, he said the only thing with PRP injection was that it starts showing results only after 4-6 weeks, so the patient should not come with an intention of immediate results.
Deepak Raheja, an orthopaedic surgeon at AIIMS, said PRP injection was an economically viable option as it costs about one-tenth of a knee replacement surgery.
"Since it is a biological injection, like mentioned earlier, its impact may vary from patient to patient. There are various studies which show that in at least 73 percent of cases, there were clinical and functional benefits and no progression of arthritis up to one year," he said.
Source: IANS
Advertisement
Advertisement
|
Advertisement
Recommended Reading
Latest General Health News

In India, youth must be aware of the diseases linked to cigarette smoking and tobacco consumption, causing a form of healthcare emergency.

Direct coastal access may represent a viable route to public health promotion, but the relationships of coastal living are not strongest among lower-income groups.

New research by Tinnitus UK has found that over four million gardeners are putting their hearing capacity at risk this summer without using safety protection.

Mucus plugs could be targeted to help reduce fatalities from chronic obstructive pulmonary disease.

The development of reliable curative therapies for multiple sclerosis could significantly reduce the economic burden of the disease on patients and wider society.